Global Plerixafor Market Growth (Status and Outlook) 2023-2029

March 2023 | 63 pages | ID: G285A1BF6F2EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream.

LPI (LP Information)' newest research report, the “Plerixafor Industry Forecast” looks at past sales and reviews total world Plerixafor sales in 2022, providing a comprehensive analysis by region and market sector of projected Plerixafor sales for 2023 through 2029. With Plerixafor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plerixafor industry.

This Insight Report provides a comprehensive analysis of the global Plerixafor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plerixafor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plerixafor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plerixafor and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plerixafor.

The global Plerixafor market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Plerixafor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Plerixafor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Plerixafor is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Plerixafor players cover sanofi-aventis. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Plerixafor market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 24MG/1.2ML
• Type II

Segmentation by application

• Non-Hodgkin's lymphoma (NHL) Patients
• Multiple myeloma (MM) Patients

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• sanofi-aventis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Plerixafor Market Size 2018-2029
  2.1.2 Plerixafor Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Plerixafor Segment by Type
  2.2.1 24MG/1.2ML
  2.2.2 Type II
2.3 Plerixafor Market Size by Type
  2.3.1 Plerixafor Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Plerixafor Market Size Market Share by Type (2018-2023)
2.4 Plerixafor Segment by Application
  2.4.1 Non-Hodgkin's lymphoma (NHL) Patients
  2.4.2 Multiple myeloma (MM) Patients
2.5 Plerixafor Market Size by Application
  2.5.1 Plerixafor Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Plerixafor Market Size Market Share by Application (2018-2023)

3 PLERIXAFOR MARKET SIZE BY PLAYER

3.1 Plerixafor Market Size Market Share by Players
  3.1.1 Global Plerixafor Revenue by Players (2018-2023)
  3.1.2 Global Plerixafor Revenue Market Share by Players (2018-2023)
3.2 Global Plerixafor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PLERIXAFOR BY REGIONS

4.1 Plerixafor Market Size by Regions (2018-2023)
4.2 Americas Plerixafor Market Size Growth (2018-2023)
4.3 APAC Plerixafor Market Size Growth (2018-2023)
4.4 Europe Plerixafor Market Size Growth (2018-2023)
4.5 Middle East & Africa Plerixafor Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Plerixafor Market Size by Country (2018-2023)
5.2 Americas Plerixafor Market Size by Type (2018-2023)
5.3 Americas Plerixafor Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Plerixafor Market Size by Region (2018-2023)
6.2 APAC Plerixafor Market Size by Type (2018-2023)
6.3 APAC Plerixafor Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Plerixafor by Country (2018-2023)
7.2 Europe Plerixafor Market Size by Type (2018-2023)
7.3 Europe Plerixafor Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Plerixafor by Region (2018-2023)
8.2 Middle East & Africa Plerixafor Market Size by Type (2018-2023)
8.3 Middle East & Africa Plerixafor Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PLERIXAFOR MARKET FORECAST

10.1 Global Plerixafor Forecast by Regions (2024-2029)
  10.1.1 Global Plerixafor Forecast by Regions (2024-2029)
  10.1.2 Americas Plerixafor Forecast
  10.1.3 APAC Plerixafor Forecast
  10.1.4 Europe Plerixafor Forecast
  10.1.5 Middle East & Africa Plerixafor Forecast
10.2 Americas Plerixafor Forecast by Country (2024-2029)
  10.2.1 United States Plerixafor Market Forecast
  10.2.2 Canada Plerixafor Market Forecast
  10.2.3 Mexico Plerixafor Market Forecast
  10.2.4 Brazil Plerixafor Market Forecast
10.3 APAC Plerixafor Forecast by Region (2024-2029)
  10.3.1 China Plerixafor Market Forecast
  10.3.2 Japan Plerixafor Market Forecast
  10.3.3 Korea Plerixafor Market Forecast
  10.3.4 Southeast Asia Plerixafor Market Forecast
  10.3.5 India Plerixafor Market Forecast
  10.3.6 Australia Plerixafor Market Forecast
10.4 Europe Plerixafor Forecast by Country (2024-2029)
  10.4.1 Germany Plerixafor Market Forecast
  10.4.2 France Plerixafor Market Forecast
  10.4.3 UK Plerixafor Market Forecast
  10.4.4 Italy Plerixafor Market Forecast
  10.4.5 Russia Plerixafor Market Forecast
10.5 Middle East & Africa Plerixafor Forecast by Region (2024-2029)
  10.5.1 Egypt Plerixafor Market Forecast
  10.5.2 South Africa Plerixafor Market Forecast
  10.5.3 Israel Plerixafor Market Forecast
  10.5.4 Turkey Plerixafor Market Forecast
  10.5.5 GCC Countries Plerixafor Market Forecast
10.6 Global Plerixafor Forecast by Type (2024-2029)
10.7 Global Plerixafor Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 sanofi-aventis
  11.1.1 sanofi-aventis Company Information
  11.1.2 sanofi-aventis Plerixafor Product Offered
  11.1.3 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 sanofi-aventis Main Business Overview
  11.1.5 sanofi-aventis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Plerixafor Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 24MG/1.2ML
Table 3. Major Players of Type II
Table 4. Plerixafor Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Plerixafor Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Plerixafor Market Size Market Share by Type (2018-2023)
Table 7. Plerixafor Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Plerixafor Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Plerixafor Market Size Market Share by Application (2018-2023)
Table 10. Global Plerixafor Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Plerixafor Revenue Market Share by Player (2018-2023)
Table 12. Plerixafor Key Players Head office and Products Offered
Table 13. Plerixafor Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Plerixafor Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Plerixafor Market Size Market Share by Regions (2018-2023)
Table 18. Global Plerixafor Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Plerixafor Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Plerixafor Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Plerixafor Market Size Market Share by Country (2018-2023)
Table 22. Americas Plerixafor Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Plerixafor Market Size Market Share by Type (2018-2023)
Table 24. Americas Plerixafor Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Plerixafor Market Size Market Share by Application (2018-2023)
Table 26. APAC Plerixafor Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Plerixafor Market Size Market Share by Region (2018-2023)
Table 28. APAC Plerixafor Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Plerixafor Market Size Market Share by Type (2018-2023)
Table 30. APAC Plerixafor Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Plerixafor Market Size Market Share by Application (2018-2023)
Table 32. Europe Plerixafor Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Plerixafor Market Size Market Share by Country (2018-2023)
Table 34. Europe Plerixafor Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Plerixafor Market Size Market Share by Type (2018-2023)
Table 36. Europe Plerixafor Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Plerixafor Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Plerixafor Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Plerixafor Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Plerixafor Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Plerixafor Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Plerixafor Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Plerixafor Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Plerixafor
Table 45. Key Market Challenges & Risks of Plerixafor
Table 46. Key Industry Trends of Plerixafor
Table 47. Global Plerixafor Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Plerixafor Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Plerixafor Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Plerixafor Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. sanofi-aventis Details, Company Type, Plerixafor Area Served and Its Competitors
Table 52. sanofi-aventis Plerixafor Product Offered
Table 53. sanofi-aventis Plerixafor Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. sanofi-aventis Main Business
Table 55. sanofi-aventis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Plerixafor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plerixafor Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Plerixafor Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Plerixafor Sales Market Share by Country/Region (2022)
Figure 8. Plerixafor Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Plerixafor Market Size Market Share by Type in 2022
Figure 10. Plerixafor in Non-Hodgkin's lymphoma (NHL) Patients
Figure 11. Global Plerixafor Market: Non-Hodgkin's lymphoma (NHL) Patients (2018-2023) & ($ Millions)
Figure 12. Plerixafor in Multiple myeloma (MM) Patients
Figure 13. Global Plerixafor Market: Multiple myeloma (MM) Patients (2018-2023) & ($ Millions)
Figure 14. Global Plerixafor Market Size Market Share by Application in 2022
Figure 15. Global Plerixafor Revenue Market Share by Player in 2022
Figure 16. Global Plerixafor Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Plerixafor Market Size 2018-2023 ($ Millions)
Figure 18. APAC Plerixafor Market Size 2018-2023 ($ Millions)
Figure 19. Europe Plerixafor Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Plerixafor Market Size 2018-2023 ($ Millions)
Figure 21. Americas Plerixafor Value Market Share by Country in 2022
Figure 22. United States Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Plerixafor Market Size Market Share by Region in 2022
Figure 27. APAC Plerixafor Market Size Market Share by Type in 2022
Figure 28. APAC Plerixafor Market Size Market Share by Application in 2022
Figure 29. China Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Plerixafor Market Size Market Share by Country in 2022
Figure 36. Europe Plerixafor Market Size Market Share by Type (2018-2023)
Figure 37. Europe Plerixafor Market Size Market Share by Application (2018-2023)
Figure 38. Germany Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Plerixafor Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Plerixafor Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Plerixafor Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Plerixafor Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Plerixafor Market Size 2024-2029 ($ Millions)
Figure 52. APAC Plerixafor Market Size 2024-2029 ($ Millions)
Figure 53. Europe Plerixafor Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Plerixafor Market Size 2024-2029 ($ Millions)
Figure 55. United States Plerixafor Market Size 2024-2029 ($ Millions)
Figure 56. Canada Plerixafor Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Plerixafor Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Plerixafor Market Size 2024-2029 ($ Millions)
Figure 59. China Plerixafor Market Size 2024-2029 ($ Millions)
Figure 60. Japan Plerixafor Market Size 2024-2029 ($ Millions)
Figure 61. Korea Plerixafor Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Plerixafor Market Size 2024-2029 ($ Millions)
Figure 63. India Plerixafor Market Size 2024-2029 ($ Millions)
Figure 64. Australia Plerixafor Market Size 2024-2029 ($ Millions)
Figure 65. Germany Plerixafor Market Size 2024-2029 ($ Millions)
Figure 66. France Plerixafor Market Size 2024-2029 ($ Millions)
Figure 67. UK Plerixafor Market Size 2024-2029 ($ Millions)
Figure 68. Italy Plerixafor Market Size 2024-2029 ($ Millions)
Figure 69. Russia Plerixafor Market Size 2024-2029 ($ Millions)
Figure 70. Spain Plerixafor Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Plerixafor Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Plerixafor Market Size 2024-2029 ($ Millions)
Figure 73. Israel Plerixafor Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Plerixafor Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Plerixafor Market Size 2024-2029 ($ Millions)
Figure 76. Global Plerixafor Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Plerixafor Market Size Market Share Forecast by Application (2024-2029)